Smart dosing for seniors: antibiotic study aims to get it just right
NCT ID NCT07494981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a personalized approach to dosing the antibiotic ceftazidime-avibactam in patients aged 60 and older. Researchers will measure drug levels in the blood and use computer models to adjust each person's dose, aiming to improve effectiveness and reduce side effects. The goal is to create a smarter, safer dosing system for older adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEFTAZIDIME-AVIBACTAM are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.